Klaria Pharma Holding Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Klaria Pharma Holding
Access all reports
Klaria Pharma Holding AB is a Swedish biotechnology and medical research company focused on developing and commercializing therapeutic drugs. The company's core technology involves a patented drug delivery platform using an alginate-based polymer film that facilitates rapid and reliable transmucosal absorption. This innovative method allows the medication to be distributed directly into the bloodstream via a mucoadhesive film, offering benefits such as shorter time to effect, increased control, and simple handling. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
KLAR
Country
🇸🇪 Sweden